| Literature DB >> 31202333 |
Christine Schirmer1, Juliane Posseckardt2, Mathias Schröder3, Markus Gläser3, Steffen Howitz4, Wolfram Scharff3, Michael Mertig5.
Abstract
Wastewater treatment plants are the main release sources of pharmaceutical compounds present in surface waters. Even at low concentrations, many of these substances have long-term adverse effects on the environment. For an efficient control of pharmaceutical removal, a real-time recognition is a prerequisite. Currently, quantification of such compounds is done in special equipped laboratories and is rather time-consuming and expensive. Here, we introduce a novel biosensor for the detection of the pharmaceutical compound diclofenac, which can be produced with low costs, is easy in handling and can be applied directly on-site. Recognition of diclofenac is based on genetically engineered yeast cells which produce green fluorescent protein in a diclofenac concentration-dependent manner. Centerpiece of the sensor is a foil-based microfluidic flow cell, which allows supply with nutrient solution and analyte while preventing loss of reporter cells. Readout of data is accomplished by a newly developed spectrometric detection unit. With this device, we are able to determine diclofenac concentrations in a range from 10 to 50 μM.Entities:
Keywords: Diclofenac; Fluorescent protein; Foil-based flow cell; Genetically engineered yeast cells; Microfluidic device; Spectrometric detection unit
Mesh:
Substances:
Year: 2019 PMID: 31202333 DOI: 10.1016/j.talanta.2019.05.058
Source DB: PubMed Journal: Talanta ISSN: 0039-9140 Impact factor: 6.057